GL1X · GenesisL1 explorer

Research workbench

Biochemical, cellular and structural characterization of novel ERK3 inhibitors

Analyse Biochemical, cellular and structural characterization of novel ERK3 inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6YLC
Type
protein
Length
1,157 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 6
EC
2.7.11.24
UniProt
Q16659
Ligands
OXW
Pockets
14 · best druggability 0.84

Structure

x-ray diffraction · 4 distinct chains · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 6 (EC 2.7.11.24)protein28238% helix, 18% strandQ16659
BMitogen-activated protein kinase 6 (EC 2.7.11.24)protein29238% helix, 17% strandQ16659
CMitogen-activated protein kinase 6 (EC 2.7.11.24)protein28040% helix, 16% strandQ16659
DMitogen-activated protein kinase 6 (EC 2.7.11.24)protein30339% helix, 18% strandQ16659

Ligands and binding sites

  • OXW · 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile · ligand · 4 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110430.840.85119OXW
210520.820.83101OXW
35580.730.8149empty
42920.660.8240empty
53930.650.7843empty

Interfaces

5 interfaces between chains.

  • A–C · 1162 Ų buried · 11 hydrogen bonds · protein-protein
  • C–D · 1115 Ų buried · 13 hydrogen bonds · protein-protein
  • B–D · 919 Ų buried · 16 hydrogen bonds · protein-protein
  • A–B · 272 Ų buried · 1 hydrogen bond · protein-protein
  • A–D · 18 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6YLC · Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors · the same entry in another collection · chain D against D, TM-score 1.00
  • Q16659 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 6 (Q16659) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.